🇺🇸 FDA
Patent

US 10973812

Ataxia therapeutic compositions and methods

granted A61KA61K31/4704A61K38/07

Quick answer

US patent 10973812 (Ataxia therapeutic compositions and methods) held by Regents of the University of Minnesota expires Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Apr 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/4704, A61K38/07, A61K47/02, A61K9/0024